Profile data is unavailable for this security.
About the company
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
- Revenue in USD (TTM)446.55m
- Net income in USD-15.55m
- Incorporated2001
- Employees987.00
- LocationAccuray Inc1240 DEMING WAYMADISON 53717United StatesUSA
- Phone+1 (608) 824-2800
- Fax+1 (408) 716-4601
- Websitehttps://www.accuray.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
InfuSystem Holdings Inc | 129.37m | 366.00k | 144.31m | 499.00 | 432.31 | 2.70 | 11.52 | 1.12 | 0.0157 | 0.0157 | 5.99 | 2.51 | 1.22 | 10.38 | 6.44 | 259,264.50 | 0.3465 | 4.60 | 0.401 | 5.69 | 49.68 | 56.43 | 0.2829 | 4.07 | 1.64 | 1.97 | 0.3898 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
Akoya Biosciences Inc | 93.22m | -60.35m | 149.98m | 330.00 | -- | 6.74 | -- | 1.61 | -1.22 | -1.22 | 1.89 | 0.4498 | 0.5605 | 1.93 | 6.34 | 282,472.70 | -36.29 | -- | -45.98 | -- | 57.57 | -- | -64.74 | -- | 1.98 | -8.00 | 0.7755 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
Acme United Corp | 192.71m | 19.45m | 155.82m | 645.00 | 8.48 | 1.50 | 6.23 | 0.8086 | 4.97 | 4.97 | 48.59 | 28.13 | 1.15 | 2.07 | 4.83 | 298,770.50 | 11.60 | 7.09 | 13.79 | 8.29 | 39.40 | 35.72 | 10.09 | 5.50 | 1.77 | 6.60 | 0.2621 | 18.81 | -1.27 | 6.88 | 486.31 | 31.08 | 9.02 | 4.84 |
Stereotaxis Inc | 23.75m | -22.08m | 163.39m | 122.00 | -- | 14.10 | -- | 6.88 | -0.265 | -0.265 | 0.285 | 0.202 | 0.5632 | 1.14 | 5.04 | 194,639.30 | -49.21 | -25.02 | -71.93 | -34.12 | 59.28 | 67.57 | -87.38 | -41.90 | 1.53 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
CVRx Inc | 44.39m | -54.39m | 166.23m | 200.00 | -- | 3.00 | -- | 3.74 | -2.57 | -2.57 | 2.10 | 2.54 | 0.4209 | 0.6253 | 5.79 | 221,965.00 | -51.56 | -- | -56.39 | -- | 84.40 | -- | -122.52 | -- | 8.85 | -18.48 | 0.3467 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
Nevro Corp | 426.10m | -77.44m | 175.23m | 1.22k | -- | 0.6376 | -- | 0.4113 | -2.12 | -2.12 | 11.69 | 7.37 | 0.7266 | 1.11 | 5.93 | 350,697.90 | -13.21 | -13.64 | -15.59 | -16.68 | 68.06 | 68.54 | -18.18 | -20.67 | 3.53 | -28.95 | 0.4433 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
Accuray Inc | 446.55m | -15.55m | 176.48m | 987.00 | -- | 3.91 | -- | 0.3952 | -0.1591 | -0.1591 | 4.54 | 0.45 | 0.9423 | 2.14 | 5.36 | 452,432.60 | -3.28 | -1.37 | -5.61 | -2.33 | 32.05 | 36.43 | -3.48 | -1.55 | 0.947 | 0.2623 | 0.7925 | -- | -0.2355 | 1.29 | -67.51 | -- | -3.54 | -- |
Neuropace Inc | 71.82m | -29.90m | 178.39m | 171.00 | -- | 18.01 | -- | 2.48 | -1.09 | -1.09 | 2.61 | 0.3392 | 0.7305 | 1.74 | 6.49 | 419,994.20 | -30.41 | -- | -34.66 | -- | 74.15 | -- | -41.63 | -- | 5.47 | -4.37 | 0.8565 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
Senseonics Holdings Inc | 24.04m | -80.46m | 181.61m | 132.00 | -- | 314.04 | -- | 7.55 | -0.1323 | -0.1323 | 0.0395 | 0.0714 | 0.1815 | 2.58 | 5.99 | 182,113.60 | -60.74 | -73.65 | -74.52 | -106.97 | 12.04 | -40.41 | -334.69 | -649.86 | 2.89 | -10.93 | 0.5802 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
Electromed Inc | 54.72m | 5.15m | 184.23m | 174.00 | 37.85 | 4.25 | 30.75 | 3.37 | 0.5791 | 0.5791 | 6.17 | 5.16 | 1.12 | 3.27 | 2.25 | 314,459.80 | 10.51 | 8.64 | 12.51 | 10.09 | 76.26 | 76.26 | 9.41 | 8.06 | 5.27 | -- | 0.00 | 0.00 | 13.83 | 11.82 | 62.67 | 21.06 | -22.23 | -- |
Semler Scientific Inc | 61.74m | 15.82m | 184.88m | 92.00 | 13.01 | 2.36 | 11.21 | 2.99 | 2.03 | 2.03 | 7.93 | 11.22 | 0.7706 | 16.26 | 9.15 | 671,097.80 | 19.74 | 38.83 | 22.00 | 44.41 | 88.67 | 90.22 | 25.62 | 32.58 | 3.66 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
Orchestra Biomed Holdings Inc | 2.08m | -55.58m | 189.12m | 56.00 | -- | 4.06 | -- | 90.97 | -1.57 | -1.57 | 0.0586 | 1.23 | 0.021 | 1.34 | 16.57 | 37,125.00 | -56.06 | -- | -64.66 | -- | 92.02 | -- | -2,673.26 | -- | 4.58 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
LifeMD Inc | 178.28m | -26.60m | 191.66m | 207.00 | -- | -- | -- | 1.08 | -0.7004 | -0.7004 | 4.70 | -0.101 | 3.59 | 6.86 | 38.19 | 861,255.40 | -44.31 | -153.05 | -333.96 | -526.91 | 88.92 | 83.66 | -12.34 | -45.44 | 0.8327 | -8.19 | 1.13 | -- | 28.15 | 78.90 | 51.27 | -- | 143.64 | -- |
Trubridge Inc | 336.56m | -52.28m | 194.48m | 3.22k | -- | 1.07 | -- | 0.5779 | -3.68 | -3.68 | 23.64 | 12.12 | 0.7947 | 196.76 | 5.88 | 104,553.30 | -12.66 | 1.25 | -14.34 | 1.41 | 48.70 | 50.40 | -15.93 | 1.56 | 1.76 | 0.6115 | 0.4985 | 45.06 | 3.91 | 3.89 | -387.73 | -- | 88.71 | -- |
Inogen Inc | 326.65m | -92.44m | 213.47m | 834.00 | -- | 1.14 | -- | 0.6535 | -3.97 | -3.97 | 13.97 | 7.91 | 0.9562 | 6.85 | 7.49 | 391,670.30 | -27.06 | -8.23 | -33.51 | -9.53 | 42.56 | 44.54 | -28.30 | -10.31 | 2.37 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 31 Mar 2024 | 6.72m | 6.77% |
Archon Capital Management LLCas of 31 Mar 2024 | 6.51m | 6.56% |
Neuberger Berman Investment Advisers LLCas of 31 Mar 2024 | 5.81m | 5.86% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 5.06m | 5.10% |
Heartland Advisors, Inc.as of 30 Jun 2024 | 3.32m | 3.35% |
Royce & Associates LPas of 31 Mar 2024 | 3.27m | 3.30% |
Renaissance Technologies LLCas of 30 Jun 2024 | 2.81m | 2.83% |
Geode Capital Management LLCas of 30 Jun 2024 | 2.13m | 2.15% |
Harbert Fund Advisors, Inc.as of 31 Mar 2024 | 1.85m | 1.86% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.81m | 1.82% |